目的 氟化钠是一种正电子计算机断层显像(PET)骨显像剂,主要用于诊断成骨活性有改变的病灶。本实验旨在考查氟化钠的药动学性质,并通过PET显像研究其诊断效果。方法 首先制备氟化钠注射液,并对其进行质量控制,然后研究其在新西兰兔体内的血液清除情况和血浆蛋白结合率,进行氟化钠PET和99Tcm-MDP SPECT显像的随机对照试验,并对显像效果进行比较。结果 制备了氟化钠注射液,检验结果均符合质控要求。氟化钠在血液中清除相半衰期为37 min,在体内的清除率(CL)为56 mL·min-1·kg-1,血浆蛋白结合率为0.57%。2种显像方式均可见全身骨骼,但氟化钠PET显像给药后30 min就可获得良好的显像效果,骨骼部位显示更为清晰,骨骼部位与肌肉的放射性摄取比明显高于99Tcm-MDP。结论 氟化钠PET骨显像性能优于99Tcm-MDP SPECT,本实验为氟化钠PET用于骨显像的临床应用提供了实验依据。
Abstract
OBJECTIVE Sodium fluoride is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity. To investigate the pharmacokinetic properties of sodium fluoride, and to study its diagnostic effects by PET imaging. METHODS This study was focused on the preparation and the quality control of sodium fluoride injection, the blood clearance and plasma protein binding rate of sodium fluoride in New Zealand rabbits, the randomized controlled trial of sodium fluoride PET and 99Tcm-MDP SPECT imaging, and comparing of the imaging results. RESULTS Sodium fluoride was prepared, the test results conformed to the requirements of the quality control. The half-life of blood clearance phase was 37 min, the clearance rate in the body was 56 mL·min-1·kg-1, and the plasma protein binding rate was 0.57%. From both sodium fluoride PET and 99Tcm-MDP SPECT imaging, the whole body skeleton were visible. However, it only took 30 min for sodium fluoride to present excellent imaging with clearer bone after administration. The radioactive uptake ratio (T/NT) of sodium fluoride between the bone and the muscle was significantly higher than the T/NT of 99Tcm-MDP.CONCLUSION Sodium fluoride PET is superior to 99Tcm-MDP SPECT for bone imaging. This study provides an experimental basis for the clinical application of sodium fluoride PET in the bone imaging.
关键词
正电子计算机断层显像 /
骨显像 /
氟化钠 /
药动学 /
药效学
{{custom_keyword}} /
Key words
positron emission tomography /
bone imanging /
sodium fluoride /
pharmacokinetics /
pharmacodynamics
{{custom_keyword}} /
中图分类号:
R969.1
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ESPOSITO M, GUISE T, KANG Y. The biology of bone metastasis. Cold Spring Harb Perspect Med, 2018,8(6):e031252.
[2] SHEN C T, QIU Z L, HAN T T, et al. Performance of 18F-fluoride PET or PET/CT for the detection of bone metastases. Clin Nucl Med, 2015, 40(2):103-110.
[3] LIU Z. Early imaging analysis of stress bone injury. Chin J Clin(Elect Ed) (中华临床医师杂志:电子版), 2014, 8(18):75-78.
[4] ZHANG H B, WEI F K, YUAN C X, et al. Experimental study on ultrasonograhy of fractures. Chin J Ultrasound Med(中国超声医学杂志), 2002,18(9):649-652.
[5] WANG R F, AN R. Nuclear Medicine(核医学). 9th ed. Beijing:People′s Medical Publishing House, 2018:137-157.
[6] SHIRRMERSTER H, GUHLMANN A, SLSNER K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization:p1anar bone scintigraphy versus 18F PET. J Nucl Med,1999, 40(10):1623-1629.
[7] BLAU M, NAGLER W, BENDER M A. Fluorine-18:a new isotope for bone scanning. J Nucl Med, 1962, 3(4):332-334.
[8] BLAU M, GANATRA R, BENDER M A. 18F-fluoride for bone imaging. Semin Nucl Med, 1972, 2(1):31-37.
[9] SUBRAMANIAN G, MCAFEE J G. A new complex of 99mTc for skeletal imaging. Radiology, 1971, 99(1):192-196.
[10] SATYAMURTHY N, PHELPS M E, BARRIO J R. Electronic generators for the production of positron-emitter labeled radiopharmaceuticals. where would PET be without them?. Clin Positron Imaging, 1999, 2(5):233-253.
[11] ZHANG Y, CHEN Y. Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases. Inter J Radiat Med Nucl Med (国际放射医学核医学杂志), 2015,39(1):96-102.
[12] WOOTTON R, DORE C. The single-passage extraction of 18F in rabbit bone. Clin Phys Physiol Meas, 1986, 7(4):333-343.
[13] LIU C X. Review of drug metabolism and pharmacokinetics studies in China . Chin Pharm J(中国药学杂志), 2010,45(2):81-89.
[14] KNAUS R M, DOST F N, JOHNSON D E, et al. Fluoride distribution in rats during and after continuous infusion of Na18F. Toxicol Appl Pharmacol, 1976, 38(2):335-343.
[15] BONTE F J, PARKEY R W, GRAHAM K D, et al. Distributions of several agents useful in imaging myocardial infarcts. J Nucl Med, 1975, 16(2):132-135.
[16] BLAKE G M, PARK-HOLOHAN S J, COOK G J, et al. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med, 2001, 31(1):28-49.
[17] GUO F H,LI M G, LI G, et al. The preparation, imaging mechanism and clinical application of PET imaging agent sodium fluoride . J Nucl Radiochem (核化学与放射化学),2017,39(2):138-144.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}